VINCOVECT 150
Composition
Each 150 g contains:
Description
The combination of lincomycin and spectinomycin exhibits additive, and in some cases, synergistic antibacterial activity. Spectinomycin demonstrates bacteriostatic or bactericidal effects, depending on the dose, primarily against Gram-negative organisms such as *Campylobacter* spp., *E. coli*, *Salmonella* spp., and *Mycoplasma* spp. Lincomycin acts predominantly as a bacteriostatic agent against Gram-positive bacteria, including *Staphylococcus* spp., *Streptococcus* spp., and *Brachyspira* spp. It should be noted that cross-resistance with macrolides may occur.
Indications
For the treatment of gastrointestinal and respiratory infections in swine and poultry caused by microorganisms sensitive to spectinomycin and lincomycin, including but not limited to *Campylobacter* spp., *E. coli*, *Mycoplasma* spp., *Salmonella* spp., *Staphylococcus* spp., *Streptococcus* spp., and *Brachyspira* spp.
Contraindications
Side Effects
Dosage and Administration
For oral administration:
Withdrawal Periods
Not for use in poultry producing eggs intended for human consumption.
Packaging
Available in 150 g containers.